Applying GRADE for diagnosis 45 2 37. Koberlein J, Kothe AC, Sieber J, Mosges R. Determining factors of patient compliance to treatment in allergic rhinitis. Asian Pacific Journal of Allergy and Immunology. 2013;31(2):148-56. doi:10.12932/AP0264.31.2.2013. 38. Loh CY, Chao SS, Chan YH, Wang DY. A clinical survey on compliance in the treatment of rhinitis using nasal steroids. Allergy: European Journal of Allergy and Clinical Immunology. 2004;59(11):1168-72. doi:10.1111/j.1398-9995.2004.00554.x. 39. Navarro A, Valero A, Rosales MJ, Mullol J. Clinical use of oral antihistamines and intranasal corticosteroids in patients with allergic rhinitis. Journal of Investigational Allergology and Clinical Immunology. 2011;21(5):363-9. 40. Ocak E, Kocaoz D, Acar B. How can we improve medical adherence to intranasal corticosteroids in children? International journal of pediatric otorhinolaryngology. 2017;100:194-7. doi:10.1016/j.ijporl.2017.07.010. 41. Pizzulli A, Perna S, Florack J, Pizzulli A, Giordani P, Tripodi S, et al. The impact of telemonitoring on adherence to nasal corticosteroid treatment in children with seasonal allergic rhinoconjunctivitis. Clinical & Experimental Allergy. 2014;44(10):1246-54. doi:10.1111/cea.12386. 42. Wang K, Wang C, Xi L, Zhang Y, Ouyang Y, Lou H, et al. A randomized controlled trial to assess adherence to allergic rhinitis treatment following a daily short message service (SMS) via the mobile phone. International archives of allergy and immunology. 2014;163(1):51-8. doi:10.1159/000356317. 43. Wong IYZ, Soh SE, Chng SY, Shek LPC, Goh DYT, Van Bever HPS, et al. Compliance with topical nasal medication - An evaluation in children with rhinitis. Pediatric Allergy and Immunology. 2010;21(8):114650. doi:10.1111/j.1399-3038.2010.01015.x. 44. Schunemann HJ, Mustafa RA, Brozek J, Steingart KR, Leeflang M, Murad MH, et al. GRADE guidelines: 21 part 2. Inconsistency, Imprecision, publication bias and other domains for rating the certainty of evidence for test accuracy and presenting it in evidence profiles and summary of findings tables. J Clin Epidemiol. 2020 doi:10.1016/j.jclinepi.2019.12.021. 45. Schunemann HJ, Mustafa RA, Brozek J, Steingart KR, Leeflang M, Murad MH, et al. GRADE guidelines: 21 part 1. Study design, risk of bias and indirectness in rating the certainty across a body of evidence for test accuracy. J Clin Epidemiol. 2020 doi:10.1016/j.jclinepi.2019.12.020. 46. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2010;182(18):E839-42. doi:10.1503/cmaj.090449.
RkJQdWJsaXNoZXIy MTk4NDMw